 Prokinetic treatment constipation-predominant irritable bowel syndrome placebo-controlled study cisapride effects prokinetic treatment cisapride patients constipation-predominant irritable bowel syndrome IBS randomized double-blind placebo-controlled study Sixty-nine IBS patients treatment mg cisapride placebo t.i.d dosage necessary mean weekly number days stool cisapride placebo group weeks treatment number days stools normal consistency week reduction severity frequency scores abdominal pain equal cisapride group placebo group abdominal distension Cisapride placebo flatulence patients overall rating response treatment good excellent week Cisapride results drug useful management constipation-predominant IBS